Introduction
Sepsis is still one of the major causes of death in developed countries. A quarter of patients who develop severe sepsis will die during their hospitalization. Septic shock is associated with the highest mortality approaching 50% in the USA [1] . In Switzerland around 20% of all death cases from 2005 until 2007 were caused by sepsis [2] . Therefore accurate diagnosis and rapid treatment of sepsis are of crucial importance. In 42% of American men and in 36% American women sepsis is caused by a respiratory tract infection [1] . Respiratory tract infections, particularly pneumonia, are the most common site of infection, and associated with the highest mortality. In most of these cases the origin of the sickness is a bacterial agent [3] . The most competent marker to detect respiratory tract infections nowadays seems to be PCT [4] . This diagnostic marker does not only help to detect bacterial infections and to prevent severe complications, but also to prevent unnecessary antibiotic therapy. Several studies demonstrated the potential of PCT-based algorithms to shorten the antibiotic therapy and to reduce the duration of hospitalization, without increasing mortality and morbidity [5] . In Switzerland the combined measurement of PCT and C-reactive protein (CRP) is a gold standard to differentiate between bacterial and non-bacterial infection in LRTI [6] . Another marker of infection is interleukin 6 (IL-6), which, however, is also elevated during inflammation in the absence of infection in some patient groups [7] .
The aim of this study was to evaluate whether a novel score the so called Intensive Care Infection Score (ICIS) [8] which is based on the measurement of certain blood parameters, could be also useful to differentiate between bacterial and non-bacterial origin in lower respiratory tract infection. Previous reports showed that ICIS is a good instrument to detect patients with a bacterial infection in the first 3 days of hospitalization [8] .
To proof the efficiency of ICIS, the score was compared to the gold standard parameters PCT and CRP and also to Interleukin-6 (IL-6).
To prevent a progression of bacterial infection and improve the outcome it is important to detect a bacterial infection as soon as possible. None of the classical infection markers (PCT, CRP and IL-6) are likely to have high sensitivity and specificity during all stages of a bacterial infection, as the patterns for their expression differ very much during the development of infection. Therefore a combined measurement of all discussed parameters seems likely. PCT rises 2 h after the onset of the infection and reaches its plateau within 12 h. This is faster than CRP which reaches its plateau after 24 h. Interleukin-6 and several other cytokines reach their peak even faster after 2 h. However, IL-6 is not an appropriate marker for lung infections in adults, as the levels decrease again very rapidly. Apart from that, the level of IL-6 rises in unspecific manner as a response to injuries [9] . Therefore, Il-6 is not a suitable biomarker for bacterial infections with the exception in infants, but is a good marker for the assessment of overall injury of a patient [10] [11] [12] .
ICIS consists of five different activation parameters such as fluorescence intensity of segmented neutrophils, the count of antibody secreting cells, the difference in hemoglobin concentration of newly formed red blood cells (reticulocytes) and mature erythrocytes, the absolute count of mature neutrophils and of the immature granulocytes. Each of these individual parameters change in a different manner in response to developing infection: some more prominently during an early infection, and others more during the mature stage of infection. These five parameters where weighted and integrated to a discriminative ICIS. It was originally created to find out which patients in the intensive care setting could potentially develop a sepsis.
Consistent with a previous report on sepsis [8] , our study demonstrated a good discriminative power of ICIS to detect bacterial infection also in patients with LRTI.
Materials and methods

Study design
A total of 264 consecutive patients admitted to the general emergency ward of the Cantonal Hospital of Aarau, Switzerland, with symptoms of lower respiratory tract infection (LRTI) were enrolled in this study. The study was following the approval of the local Ethical Committee. Patients older than 18 years of either gender, were included after informed consent had been obtained. Inclusion criteria were: Suspicion of LRTI, i.e. acute bronchitis, acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD) or community-aquired pneumonia consisting of at least one respiratory symptom (cough, sputum production, dyspnea, tachypnea, pleuritic pain) and one auscultatory finding or systemic inflammatory signs (body temperature higher than 38 °C, shivers, leucocyte count higher than 10 × 10 9 or lower than 4 × 10 9 cells/L). The observation period was a maximum of 38 days and ended with patient's discharge or death. Cultures were taken from sputum, swab (from wound, catheter, throat, etc.) or blood. A patient was determined suffering from a bacterial infection based on a positive microbiological culture or the obvious clinical signs of a bacterial infection.
All vital parameters such as temperature, heart rate, respiratory rate and blood pressure were assessed once daily. All laboratory parameters such as PCT, CRP, IL-6, ICIS, glucose, hematocrit, albumin and D-dimer were determined every time a blood sample was taken.
Parameter analysis
Blood samples were taken via routine tap and collected in plastic Vacutainer ® (BD Becton, Dickinson and Company, USA) and were analysed within 2 h after blood draw. Procalcitonin (PCT) in heparinised plasma was measured using Kryptor (Brahms Thermo Fischer Scientific, Germany). C-Reactive Protein (CRP) was assessed with a turbidimetric assay in heparinized plasma on Vista ® 1500 (Siemens Healthceare diagnostics GmbH, Germany). An IMMU-LITE 2000 XPi Immunoassay System Siemens healthcare diagnostics immunoluminometric assay (CLIA) (Siemens, Germany) was used to measure IL-6 in serum. Hemogram (erythrocyte count, leucocyte count, thrombocyte count) was measured on a routine analyser (XN, Sysmex, Japan) out of EDTA blood.
Residual blood from routine blood samples was used for the analysis of ICIS. ICIS was measured on a research fluorescence flow hematology analyser with fully automated gating (Sysmex, Kobe, Japan) [8] . For the detection of cell shape and internal structure, blood cells were permeabilized by using membrane surfactant reagents. Information about cell content, intracellular structure and nucleic acids was obtained by fluorescence labeling.
ICIS Score
The ICIS score was originally established in a cohort of 70 consecutive patients with SIRS [8] . The ICIS score is composed of five blood-cell derived parameters characterizing the early innate immune response: (1) mean fluorescence intensity of mature (segmented) neutrophils (NEUT-SFL); (2) absolute count of segmented neutrophils (#NEUT); (3) the count of immature granulocytes (#IG); (4) the count of antibody secreting lymphocytes (#ASL) and (5) the difference in hemoglobin concentration of newly formed red blood cells compared to mature ones (Delta-H e ).
Each of these individual parameters change in a different manner and at different time points as a response to developing infection. So, in the first minutes after the infection onset neutrophils in the blood stream are activated by the antigens of the microorganisms. Membrane composition of activated cells differs to that of inactivated cells, due to expression of certain signal molecules and receptors as a response to activation. Membranes of activated cells are more susceptible to perforation by reagents of the hematology analyser, and therefore more fluorescent dye can penetrate an activated cell and bind cytoplasmatic bioactive proteins and the ribonucleic acids. This leads to a higher cytoplasmatic fluorescence intensity of activated cells. Increased fluorescence of neutrophils (high NEUT-SFL) is the earliest sign of infection. Next, as neutrophils are used up in the blood to fight bacteria by the means of phagocytosis and neutrophils traps, more neutrophils are released from the pool in the bone marrow, leading to a higher count of segmented neutrophils in the peripheral blood (#NEUT). Next, as the neutrophil pool in the bone marrow is exhausted, immature granulocytes are released from the bone marrow into the blood stream, which is reflected by a higher #IG count and depicts severity of infection. Some circulating B-lymphocytes can differentiate to the so called T-independent unspecific IgM antibody synthesizing B-lymphocytes as immune response to bacterial lipopolysaccharide. The number of antibody synthesizing B-lymphocytes in the peripheral blood increases, which corresponds to a higher ASL count. Finally, as the infection progresses, hemoglobin is locked away in the macrophages as one of the mechanisms of the antibacterial defense mechanisms. This leads to a lower hemoglobinization of newly formed reticulocytes, which is reflected by the decrease of Delta-H e value (the difference in hemoglobin concentration of newly formed red blood cells compared to mature ones).
The final score is a sum of the individual scores for each of the five above mentioned parameters, which responding to infection depends on to type of infection and time after onset of infection, and the absolute possible maximum for ICIS equals to 20. ICIS score evaluation and ICIS comprised parameters was first described by Nierhaus et al. [8] .
Statistical analysis
Data was analysed using MedCalc for Windows, Version 11.3.3.0 (MedCalc Software, Mariakerke, Belgium). The Kolmogorov-Smirnov test was applied to check if continuous variables were normally distributed, with p > 0.05 defined as non-significant and thereby data normally distributed. Differences between patient groups were assessed using Student's T-test for normally and Mann-Whitney U-test for non-normally distributed variables. In addition receiver operator characteristic (ROC) curve analyses were conducted and an area under curve (AUC) was calculated to determine the combined sensitivities and specificities for the parameters.
Results
Patient characteristics
Two hundred and sixty four patients admitted to the emergency ward of the Cantonal Hospital of Aarau with lower respiratory tract infection (LRTI) with a mean age of 62.9 (range 18-95 years) were enrolled into this study ( Table 1 ). The median of the length of stay (LOS) was 7.6 days (range of 1-38 days) the mortality was at 7.2% (19 of 264 patients died). Patients were categorized in five different groups according to diagnosis: Bronchitis (n = 27), acute exacerbation of chronic obstructive pulmonary disease (AECOPD) (n = 47), community acquired pneumonia (CAP) (n = 149), influenza (n = 7) and a remaining group of patients with lower respiratory infections who could not be assigned to one of the groups (n = 39). Each group was additionally divided into bacterially infected or not bacterially infected. Bacterial infection was found in 37% of patients with a diagnosed bronchitis, 30% of patients with a diagnosed AECOPD, 74% of patients with a diagnosed CAP and 28% of the patients in the remaining group. Positive blood cultures showed a variety of pathogens, including gram negative, gram positive bacteria and fungi (gram positive cocci (n = 26), Candida albicans (n = 19), Streptococcus pneumonia (n = 29), Haemophilus influenzae (n = 10), Escherichia coli (n = 9) and 67 infections of other origins. Although not statistically significant, a trend for Patients characteristics are displayed for all patients (n = 264) and separately for groups with bacterial infection (n = 141) or without bacterial infection (n = 123). All data are given in absolute numbers, except for ABx-pretreatment and mortality which is given in %. Statistically significant differences between both patient groups with or without bacterial infection are given as death of a LRTI was detectable when a bacterial infection was present (9.9% of the in bacterially infected patients and 4.1% of non-bacterially infected patients died, respectively). Bacterially infected patients stayed significantly longer in hospital (mean 9.5 days, range between 1 and 38 days) than non-bacterially infected patients (mean 5.5 with a range between 0 and 21 days). The mean length of antibiotic therapy was 6.3 days with a range of 0-37 days, being longer for patients with bacterial infections (mean 9.1 days, range 0-37 days) compared to patients with non-bacterial infections (mean 3.1 days, range 0-21 days). Eighteen percentage of all patients included into this study where already under antibiotic therapy, when they entered hospital, even though 16% of these patients had no bacterial infection.
Comparison of inflection markers
The dynamic of marker expression (ICIS, CRP, PCT and IL-6) in patients with bacterial and non-bacterial LRI was observed during the first 3 days of hospitalization (Figure 1 ). The ICIS score of patients with non-bacterial infection was with a 95% confidence interval (CI) always below three, whereas the ICIS score for patients who were bacterially infected was always over five (with a 95% CI). These results were comparable to CRP which is often used at the first infection check. IL-6 is very high and always over 200 ng/L on the first day of hospitalization in bacterially-infected persons and then rapidly sank to around 50 ng/L at day two. IL-6 in patients with non-bacterial Infection had an IL-6 value under 75 ng/mL on day one and a lower value at around 50 ng/L after day two. The measurements of PCT showed a high variability in day one to three (between 1 and 13 g/L) in bacterially infected persons, but showed a good consistency (under 1 g/L) in non-infected persons.
The ICIS cut off value of five to detect bacterial infection was calculated using ROC analysis; this cut-off showed the optimal specificity and sensitivity with the AUC of 0.981 for day one of hospitalization ( Figure 2 ).
The power of ICIS to differentiate between bacterial infection and non-bacterial infection
The discriminative power of ICIS to differentiate between bacterial and non-bacterial LRT infections was compared to that of CRP, PCT and IL-6 during three time periods: The first day of hospitalization, the second day and the overall time of hospitalization, using the ROC-curve analysis (Figure 2 ). In the first day ICIS performed significantly better than CRP (p > 0.0001) but not significantly better than PCT nor IL-6. On the second day of hospitalization ICIS performed significantly better than all the other parameters (against CRP p < 0.03, against IL-6 p < 0.003 and against PCT p < 0.03). Over the entire hospital stay ICIS performed significantly better than CRP (p < 0.0001) and IL-6 (p < 0.0001). Regarding the whole length of stay PCT showed a statistically better performance than CRP and IL-6 (p < 0.001).
Forty seven percentage of the outpatients included in this study had no bacterial infection and therefore did not need antibiotic treatment (Table 1) . Nevertheless 16% of patients without bacterial infection were under antibiotic treatment upon admission to hospital.
Discussion
Althougt the population size with 264 patients is rather low the statistical significance of the results encourages the authors to claim that our study demonstrates that the Predictive value for infection was computed using ROC analysis. Receiver operator curves are displayed for day 1 (n = 242; infection pos = 119; infection neg = 123); day 2 (n = 91; infection pos = 59; infection neg = 32) and all days (n = 733; infection pos = 435; infection neg = 298). In addition AUC values are given for day 1, day 2 and all days (day 1-24). Statistically significant differences between parameters are given in table with p < 0.05*; p < 0.005**; p < 0.0005***. ICIS, Intensive Care Infection Score; CRP, C-reactive protein; IL-6, interleukin-6; PCT, procalcitonin.
discriminative power of ICIS to differentiate between bacterial and non-bacterial infection in LRTI is as good as the commonly used infection biomarkers PCT, CRP and IL-6. Based on the fact that this results match with two other sepsis studies comparing ICIS [8] on one hand and the mean cell volume of neutrophils and monocytes compared with C-reactive protein, interleukin-6 and white blood cell count [13] on the other hand, supports the hypothesis that ICIS can be used as a new diagnostic score in the early differentiation between bacterial infections and non-bacterial infections. A differentiation between bacterial species is not possible with ICIS.
ICIS is based on the combined measurement of certain blood cell parameters and for this study was conducted on a modified hematology analyser (XN, Sysmex, Japan). On that account no additional reagent, material and personal costs were generated.
ICIS is calculated by the use of following five parameters: -The fluorescence intensity of neutrophils (NEUT-SFL),
showing the instantaneous neutrophil activity.
-The antibody secreting lymphocytes (ASL), showing a highly specific reaction to infection. -The difference in cellular hemoglobin content (Delta-H e ) between circulating erythrocytes and newly formed reticulocytes showing inflammation induces anemia. -The total number of mature neutrophils (NEUT#) and the immature neutrophils (IG#), both depicting the bone marrow response releasing innate immune cells and their precursors, depending on phase and severity of infection.
In Switzerland PCT is currently the recommended biomarker for the diagnosis of respiratory tract infections originated by bacteria [6] . The performance of ICIS was comparable to that of PCT on the first day of hospitalization. On the second day of hospitalization ICIS showed even a better performance than PCT. CRP is a widely used biomarker when PCT is not available and is often the first choice in general practitioner's (GP) offices. ICIS demonstrated a better diagnostic performance than CRP during the whole observation period and in the first 2 days of hospitalization. If ICIS could be calculated on a cheap hematological analyser in GP laboratories this could be an advantage for the diagnostic triage. A better or comparable performance of ICIS differentiating bacterial from non-bacterial LRTI was also observed when compared to IL-6 except for the day of admission. Even though ICIS did not perform significantly better than PCT and IL-6 on the day of admission, its advantage is the accessibility of the results within minutes after blood draw, measured on a modified hematology analyser; equipped by the special software algorithms and not requiring additional reagents. This may be cost reducing because PCT (84 CHF) and IL-6 (87 CHF) are quite expensive parameters, whereas the cost of ICIS testing is comparable to CRP (10 CHF) cost. Apart from that, PCT and IL-6 tests are often unavailable in the offices of general practitioners. A blood analyser providing ICIS in combination with CRP testing could therefore be a cost-efficient method for infection monitoring in the first 2 days of hospitalization but could also be useful as a point of care device in the GP offices because a differential blood count will be conducted anyway.
Due to antibiotic feeding in farming and imprudent use in treating viral infections in medicine nowadays the antibiotic resistance of pathogens is rising [14] . As long as microbiological analysis is taking several days and cannot be replaced by fast genomic and proteomic analysis [15] practitioners decisions are felt upon clinical appearance of the patient and biochemical parameter analyses. Therefore prompt differentiation of bacterial from non-bacterial infection based on new biomarkers like ICIS would help practitioners today to improve patients' outcomes and to reduce the risk of further resistances especially in respiratory tract infections.
Although ICIS shows a good performance during all the measured time points, ICIS like any other inflammation marker has its strengths and weaknesses depending on the time point of the disease. Biomarkers for inflammation should therefore always been looked at in combination with other markers and the clinical appearance. None of the mentioned inflammation markers can be used as the one and only gold standard. But with ICIS we have a new parameter to enlarge the palette of biomarkers giving us a better understanding of the development of bacterially originated diseases and therefore ICIS may help practitioners to make faster decisions to improve clinical outcomes and to minimize unnecessary antibiotic treatment. The search after a good method to discriminate between bacterial and no-bacterial infections based on blood cell differentiation is rather old [16] [17] [18] [19] [20] .
But until now no cheap and practicable method was available. With ICIS we hope to have found a hematological score which helps to include, already described hematological parameters into the early detection of bacterial infection.
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